Rather than having a deterrent effect, the number of Big Pharma high profile criminal settlements is increasing and the settlements are getting bigger.

Read More

Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers and their governmental and industrial…

Read More
This entry is part 5 of 5 in the series Nuremberg Code

The Nuremberg Code [from Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. Nuremberg, October 1946 – April 1949. Washington, D.C.: U.S. G.P.O, 1949 – 1953.]  Permissible Medical Experiments The great weight of the evidence before us is to the effect that certain types of medical experiments on human…

Read More

Commonly recommended Treatments found Worthless Wed, 19 Mar 2003 Independent analyses of the clinical studies upon which widely recommended drug treatments have been based, have now been found to be fatally faulty, and the drugs are deemed worthless. An analysis of 83 studies found that drugs used to treat 90,000 hospitalized babies and toddlers with…

Read More

Anthrax Vaccine Damage Done – London Times Tue, 26 Nov 2002 A riveting report in the London Times reveals more facts about the US anthrax vaccine debacle. The Times reports it “has looked at thousands of pages of government, FDA, Army, congressional and medical reports stretching back 30 years. The extraordinary story of this anthrax…

Read More

FDA Strong Drug Ties-Less Monitoring – UK MHRA Mon, 6 Dec 2004 A front page article in The New York Times provides a historical perspective to the shift in FDA’s focus (in 1992) from watchdog safeguarding the public against hazardous drugs, food and medical devices, to its current role as industry’s marketing facilitator. Dr. David…

Read More

Lies & Broken Promises_Drug firm Websites Fail to Disclose Test Data Sun, 9 Jan 2005 One year after PhRMA’s publicized proclamation of its “commitment to transparency” The Boston Globe reviewed pharmaceutical company websites searching for disclosure of clinical trial data. The Globe found that this voluntary approach failed miserably: “Last year’s commitment by members of…

Read More

Corporate Culture of Denial Results in Preventable Deaths Fri, 7 Jan 2005 Failure to disclose the hazardous effects of Vioxx and Prozac are evidence of a corporate culture that has run amok. Uncovered company documents – some obtained through litigation, others unearthed by whistleblowers – reveal that the manufacturers knew of the hazardous side effects…

Read More